Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

1D09C3

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Abstract1D09C3 is a human monoclonal IgG4-type antibody against human leukocyte antigen-DR (HLA-DR) which has demonstrated pro… Expand
  • figure 1
Is this relevant?
2009
2009
Antibodies of the IgG4 subclass, directed against cell surface antigens have received attention as therapeutic molecules due to… Expand
Is this relevant?
2007
2007
To investigate the therapeutic activity of the fully human anti-HLA-DR antibody 1D09C3 in multiple myeloma (MM), we reevaluated… Expand
Is this relevant?
2006
2006
The fully human anti-HLA-DR antibody 1D09C3 has been shown to delay lymphoma cell growth in severe combined immunodeficient (SCID… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Significant proportions of patients with non-Hodgkin lymphoma (NHL), relapsed Hodgkin lymphoma (HL), and chronic lymphocytic… Expand
Is this relevant?